NEBIVOLOL
NEBIVOLOL
Products
Contact Us

We are here to help in anything you need. Please use our online system or send an email to .

NEBIVOLOL

Inquiry

Catalog NumberPR99200096

CAS Number99200-09-6

CategoryOphthalmic Agents

NEBIVOLOL
Description Nebivolol is a beta-Adrenergic Blocker. The mechanism of action of nebivolol is as an Adrenergic beta-Antagonist.
Synonyms (-)-Nebivolol; (Rac)-Nebivolol; Vasoxen
IUPAC Name 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol
Molecular Weight 405.4
Molecular Formula C22H25F2NO4
InChI KOHIRBRYDXPAMZ-UHFFFAOYSA-N
InChI Key InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2
Drug Categories Adrenergic Agents; Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Agents causing hyperkalemia; Alcohols; Amines; Amino Alcohols; Antiarrhythmic agents; Antihypertensive Agents; Antihypertensive Agents Indicated for Hypertension; Benzopyrans; Beta blocking agents and calcium channel blockers; Beta Blocking Agents and Thiazides; Beta Blocking Agents, Selective; Beta Blocking Agents, Selective, and Thiazides; Beta-Blockers (Beta1 Selective); Bradycardia-Causing Agents; Cardiovascular Agents; Cytochrome P-450 CYP2C19 Substrates; Cytochrome P-450 CYP2D6 Substrates; Cytochrome P-450 CYP3A Substrates; Cytochrome P-450 CYP3A4 Substrates; Cytochrome P-450 Substrates; Ethanolamines; Heterocyclic Compounds, Fused-Ring; Hypotensive Agents; Neurotransmitter Agents; Pyrans; Vasodilating Agents
Drug Interactions Abaloparatide-The risk or severity of adverse effects can be increased when Nebivolol is combined with Abaloparatide.
Abametapir-The serum concentration of Nebivolol can be increased when it is combined with Abametapir.
Abatacept-The metabolism of Nebivolol can be increased when combined with Abatacept.
Abiraterone-The metabolism of Nebivolol can be decreased when combined with Abiraterone.
Abrocitinib-The metabolism of Abrocitinib can be decreased when combined with Nebivolol.
Isomeric SMILES C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O
Standard In-house
Therapeutic Category Ophthalmic Agents
Type Small Molecule

It should be noted that our service is only used for research, not for clinical use.